[ad_1] A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising…
Tag:
New Product/Service Testing
-
-
STOCK MARKET
First Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trial
by userby user[ad_1] Here were some of the most active stocks in premarket trade, as U.S. stock…
-
[ad_1] Novartis AG said Monday that a trial evaluating breast-cancer drug Kisqali met its primary…
-
[ad_1] AstraZeneca PLC on Monday said its cancer drug Enhertu has shown clinically meaningful and…
-
[ad_1] AbbVie Inc. executives lowered their outlook for the quarter and year in a filing…
-
[ad_1] Novartis AG said Monday that a trial to evaluate prostate-cancer drug Pluvicto met its…
-
STOCK MARKET
GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint
by userby user[ad_1] GSK PLC said Friday that a Phase 3 trial for its Jemperli treatment for…
-
[ad_1] Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug…
-
STOCK MARKET
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
by userby user[ad_1] A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and…
-
STOCK MARKET
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
by userby user[ad_1] Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker…